The Rhapsody Biologics Platform

Our initial data has been collected and validated in the area of Hepatitis B; however the platform is applicable to any indication where human variability and pathogen variability impact outcomes.  Our pipeline includes developing programs for HPV (human papillomavirus shown to cause cervical cancer), tuberculosis (TB) and the oncology field.